MARC details
000 -LEADER |
fixed length control field |
05307nam a22006135i 4500 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
TR-AnTOB |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20231109085809.0 |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
cr nn 008mamaa |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
220709s2022 sz | s |||| 0|eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9783030827434 |
024 7# - OTHER STANDARD IDENTIFIER |
Standard number or code |
10.1007/978-3-030-82743-4 |
Source of number or code |
doi |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
TR-AnTOB |
Language of cataloging |
eng |
Description conventions |
rda |
Transcribing agency |
TR-AnTOB |
041 ## - LANGUAGE CODE |
Language code of text/sound track or separate title |
İngilizce |
060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
WR 165 |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MJK |
Source |
bicssc |
|
Subject category code |
MED017000 |
Source |
bisacsh |
|
Subject category code |
MJK |
Source |
thema |
096 ## - LOCALLY ASSIGNED NLM-TYPE CALL NUMBER (OCLC) |
Classification number |
WR165EBK |
245 10 - TITLE STATEMENT |
Title |
Cutaneous Drug Hypersensitivity |
Medium |
[electronic resource] : |
Remainder of title |
Clinical Features, Mechanisms, Diagnosis, and Management / |
Statement of responsibility, etc. |
edited by Andreas J. Bircher, Howard I. Maibach, Knut Brockow, Annick Barbaud. |
250 ## - EDITION STATEMENT |
Edition statement |
1st ed. 2022. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
Cham : |
Name of producer, publisher, distributor, manufacturer |
Springer International Publishing : |
-- |
Imprint: Springer, |
Date of production, publication, distribution, manufacture, or copyright notice |
2022. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
1 online resource |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
computer |
Media type code |
c |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
online resource |
Carrier type code |
cr |
Source |
rdacarrier |
347 ## - DIGITAL FILE CHARACTERISTICS |
File type |
text file |
Encoding format |
PDF |
Source |
rda |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Part I. General aspects of drug hypersensitivity -- Chapter 1. Terminology, classifications, chronology -- Chapter 2. Epidemiology -- Chapter 3. Clinical manifestations: Cutaneous signs and syndromes -- Chapter 4. Clinical manifestations: Other organs (kidney, gut, heart, brain etc.) -- Chapter 5. Danger signs in drug hypersensitivity and severity SCORES -- Chapter 6. Pathomechanisms in Drug Hypersensitivities -- Part II. Diagnostic methods -- Chapter 7. Skin tests -- Chapter 8. Serological tests -- Chapter 9. T cell tests -- Chapter 10. Basophil activation tests -- Chapter 11. Histopathology of drug induced exanthemas -- Part III. Management -- Chapter 12. Drug desensitization in immediate-type hypersensitivity -- Chapter 13. Documentation allergy card/pass -- Part IV. Drug hypersensitivity in specific populations -- Chapter 14. Children and Adolescents -- Chapter 15. HIV-Infection and AIDS -- Chapter 16. Oncology. immune checkpoint Inhibitors -- Chapter 17. MC releasing syndromes in drug hypersensitivity -- Part V. Eliciting Drugs -- Chapter 18. Penicillins -- Chapter 19. Cephalosporin Allergy -- Chapter 20. Other Antibiotics -- Chapter 21. Other Antiinfectious drugs -- Chapter 22. Analgesics and non-steroidal antiphlogistic drugs -- Chapter 23. Periinterventional hypersensitivity: Anesthetic drugs and materials -- Chapter 24. Muscle relaxants -- Chapter 25. Anticoagulants -- Chapter 26. Biological drugs -- Chapter 27. Hormones (delayed) -- Chapter 28. Vaccines -- Chapter 29. Antiepileptic and psychotropic drugs -- Chapter 30. PROTON PUMP INHIBITORS -- Chapter 31. Diagnostic agents -- Chapter 32. Hypersensitivity to blood pressure agents -- Chapter 33. Iron preparations -- Chapter 34. Vitamins and supplements -- Chapter 35. Anti-tumor drugs / Cytostatics -- Chapter 36. Photosensitizing drugs -- Chapter 37. Topically applied drugs -- Chapter 38. Additives: Preservatives, Antioxidants (sulfites), Colors, dyes and other. |
520 ## - SUMMARY, ETC. |
Summary, etc. |
This book covers all aspects of hypersensitivity to drugs, providing practical information for non-specialist physicians as well as addressing issues of interest to practitioners in different specialties and presenting the expert knowledge required by specialist allergists and immunologists. The opening, general section discusses basics such as clinical manifestations, histopathology, mechanisms, risk factors, drug hypersensitivity in particular populations, and the full range of diagnostic methods. The second part of the book provides concise information on the most important drug classes and guides the reader on how to proceed when patients present with a suspected reaction. For each drug class, the current level of evidence for use of the different diagnostic tools, including skin tests, provocation tests, and in vitro tests, is clarified, and management options, outlined. The inclusion of helpful tables and algorithms is designed to aid in decision making. Drug hypersensitivity is among the more complex allergological issues, and this book will meet the needs of general practitioners, internists, and specialists. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Dermatology. |
|
Topical term or geographic name entry element |
Allergy. |
|
Topical term or geographic name entry element |
Internal medicine. |
|
Topical term or geographic name entry element |
Pharmacovigilance. |
|
Topical term or geographic name entry element |
Primary care (Medicine). |
|
Topical term or geographic name entry element |
Family medicine. |
|
Topical term or geographic name entry element |
Dermatology. |
|
Topical term or geographic name entry element |
Allergology. |
|
Topical term or geographic name entry element |
Internal Medicine. |
|
Topical term or geographic name entry element |
Drug Safety and Pharmacovigilance. |
|
Topical term or geographic name entry element |
Primary Care Medicine. |
|
Topical term or geographic name entry element |
General Practice and Family Medicine. |
653 #0 - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
Drug Eruptions |
|
Uncontrolled term |
Skin -- drug effects |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Bircher, Andreas J. |
Relator term |
editor. |
Relator code |
edt |
-- |
http://id.loc.gov/vocabulary/relators/edt |
|
Personal name |
Maibach, Howard I. |
Relator term |
editor. |
Relator code |
edt |
-- |
http://id.loc.gov/vocabulary/relators/edt |
|
Personal name |
Brockow, Knut. |
Relator term |
editor. |
Relator code |
edt |
-- |
http://id.loc.gov/vocabulary/relators/edt |
|
Personal name |
Barbaud, Annick. |
Relator term |
editor. |
Relator code |
edt |
-- |
http://id.loc.gov/vocabulary/relators/edt |
710 2# - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Uniform Resource Identifier |
<a href="https://doi.org/10.1007/978-3-030-82743-4">https://doi.org/10.1007/978-3-030-82743-4</a> |
Materials specified |
Springer eBooks |
Public note |
Online access link to the resource |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
National Library of Medicine |
Koha item type |
E-Book |